Extension Study Evaluating the Safety and Efficacy of Subcutaneous Tocilizumab (RoActemra/Actemra) Administration in Systemic and Polyarticular-Course Juvenile Idiopathic Arthritis

PHASE1CompletedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

July 16, 2014

Primary Completion Date

November 24, 2021

Study Completion Date

November 24, 2021

Conditions
Juvenile Idiopathic Arthritis
Interventions
DRUG

Tocilizumab

162 mg tocilizumab will be administered by SC injection at the following intervals: pJIA participants less than (\<) 30 kilograms (kg): every 3 weeks; pJIA participants greater than or equal to (\>=) 30 kg: every 2 weeks; sJIA participants \<30 kg: every 2 weeks; sJIA participants \>/= 30 kg: once weekly

Trial Locations (31)

2145

Westmead Hospital; Paediatric Rheumatology, Westmead

3052

Royal Children'S Hospital; Paediatric Rheumatology, Parkville

13353

Charité Campus; Virchow Klinikum Berlin, Berlin

27705

Duke University, Durham

28034

Hospital Ramon y Cajal ; Servicio de Reumatologia, Madrid

28046

Hospital de La Paz; Unidad de Reumatologia Pediatrica, Madrid

44195

Cleveland Clinic Fndn, Cleveland

46026

Hospital Universitario la Fe: Servicio de Reumatologia Pediatrica, Valencia

53757

Asklepios Klinik; Zentrum für Allgemeine Pädiatrie und Neonatologie, Sankt Augustin

60637

University of Chicago Hospital, Chicago

64460

Hospital Universitario Dr. Jose Eleuterio Gonzalez; Pediatria, Monterrey

72202

Arkansas Children's Hospital Research Institute, Little Rock

74135

Healthcare Research Consultants, Tulsa

79106

Uniklinikum Freiburg Zentrum für Kinder- und Jugendmedizin; Pädiatrische Infektio- u. Rheumatologie, Freiburg im Breisgau

84109

University of Utah; Immunology/Rheumatology/Allergy, Salt Lake City

94275

CH de Bicêtre; Pediatrie Generale, Le Kremlin-Bicêtre

98105

Seattle Children's Hospital, Seattle

119991

SI Sceintific children health center RAMS, Moscow

07601

Hackensack University Medical Center; Pediatric Rheumatology, Hackensack

45229-3039

Cincinnati Children'S Hospital Medical Center; Division of Rheumatology, Cincinnati

C1270AAN

Hospital Gral de Niños Pedro Elizalde, Buenos Aires

X5000XAF

Hospital de Ninos de la Santisima Trinidad; Hematología, Córdoba

04026-000

Universidade Federal de Sao Paulo - UNIFES, São Paulo

05403-900

Hospital das Clinicas - FMUSP, São Paulo

T3B 6A8

Alberta Children'S Hospital, Calgary

M5G 1X8

The Hospital for Sick Children, Toronto

00165

Irccs Ospedale Pediatrico Bambin Gesu - Dip. Di Medicina, Rome

06720

"Hospital Infantil de México Federico Gomez; Rheumatology", México

08950

Hospital Sant Joan De Deu; Servicio de Reumatologia Pediatrica, Esplugas de Llobregat

BS2 8BJ

Bristol Royal Hospital for Children; Rheumatology Department, Bristol

L12 2AP

Alder Hey Children's NHS Foundation Trust, Liverpool

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT02165345 - Extension Study Evaluating the Safety and Efficacy of Subcutaneous Tocilizumab (RoActemra/Actemra) Administration in Systemic and Polyarticular-Course Juvenile Idiopathic Arthritis | Biotech Hunter | Biotech Hunter